Sanford Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sanford Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013634
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox cosmetic, breast cancer risk consultation, breast radiology, cancer risk assessment and cancer screenings. It also provides cardiac electrophysiology, cardiac rehabilitation, cardiology, cardiovascular surgery, centering pregnancy, chemical peels, child life specialists, child services, counselling, family medicine, weight loss surgery, chiropractic, cleft lip and cleft palate, colorectal screenings, colorectal surgery, colposcopy, cosmetic laser treatments, and others. The center also conducts research and clinical trials for advancing disease therapy and prevention. Sanford is headquartered in Sioux Falls, South Dakota, the US.

Sanford Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Health, Medical Devices Deals, 2011 to YTD 2017 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanford Health, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Sanford Health To Acquire Assets Of Clearwater Health 11
Sanford Health Acquires Lake Region Bone & Joint Surgeons 12
Venture Financing 13
InGeneron Raises USD20 Million in Series D Financing 13
Partnerships 14
Caladrius Biosciences Enters into Development Agreement with Sanford Research 14
Merger 15
Sanford Health Completes Merger With Medcenter One 15
North Country Health Services Completes Merger With Sanford Health 16
Equity Offering 17
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 17
Caladrius Biosciences to Raise USD21 Million in Private Placement of Shares 19
Acquisition 21
Sanford Health Plans To Acquire Fairview Health Services 21
Sanford Health Acquires Hematech, Drug Development Company 22
Sanford Health Completes Acquisition Of Hillsboro Medical Center 23
Sanford Health – Key Competitors 24
Sanford Health – Key Employees 25
Sanford Health – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 27
Recent Developments 28
Government and Public Interest 28
Sep 16, 2016: NIH selects Sanford for grant to move cancer research to clinical trials 28
Product News 29
Jul 19, 2016: Sanford physician assists in developing new treatment to prevent nausea, vomiting caused by chemotherapy 29
Apr 20, 2017: Oncology group chooses Sanford for first clinical trial 30
Mar 31, 2016: Type 1 diabetes cell therapy trial enrolls first patient at Sanford 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Sanford Health, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Health, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Health, Medical Devices Deals, 2011 to YTD 2017 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanford Health To Acquire Assets Of Clearwater Health 11
Sanford Health Acquires Lake Region Bone & Joint Surgeons 12
InGeneron Raises USD20 Million in Series D Financing 13
Caladrius Biosciences Enters into Development Agreement with Sanford Research 14
Sanford Health Completes Merger With Medcenter One 15
North Country Health Services Completes Merger With Sanford Health 16
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 17
Caladrius Biosciences to Raise USD21 Million in Private Placement of Shares 19
Sanford Health Plans To Acquire Fairview Health Services 21
Sanford Health Acquires Hematech, Drug Development Company 22
Sanford Health Completes Acquisition Of Hillsboro Medical Center 23
Sanford Health, Key Competitors 24
Sanford Health, Key Employees 25
Sanford Health, Other Locations 26
Sanford Health, Subsidiaries 26
Sanford Health, Joint Venture 27

★海外企業調査レポート[Sanford Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Visteon Corporation:企業のM&A・事業提携・投資動向
    Visteon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Visteon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Freeport-McMoRan Inc:企業の戦略・SWOT・財務情報
    Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report Summary Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bank of Jinzhou Co Ltd :企業の戦略・SWOT・財務情報
    Bank of Jinzhou Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Jinzhou Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Saft Groupe SA:企業の戦略的SWOT分析
    Saft Groupe SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Distilleries Company of Sri Lanka PLC:戦略・SWOT・企業財務分析
    Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report Summary Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Yung Shin Pharma Ind Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yung Shin Pharma Ind Co Ltd (Yung Shin Pharma), a subsidiary of YungShin Global Holding Corporation is a distributor of veterinary drugs, diagnostic kits and active pharmaceutical drugs. The company’s products include carlipin, glix, macgel, diabetin, domper, kascoal, biotase, bisacodyl and …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • CRH Medical Corp (CRH):企業の財務・戦略的SWOT分析
    Summary CRH Medical Corp (CRH Medical), is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medi …
  • Quilvest Wealth Management:企業の戦略・SWOT・財務分析
    Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PEP-Therapy SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary PEP-Therapy SAS (PEP-Therapy) is a medical biotechnology company that develops targeted therapies for the treatment of cancer. The company develops cell penetrating and interfering peptides for the intracellular delivery of targeted therapies. Its pipeline products include PEP-010. PEP-Thera …
  • Eurobank Ergasias SA:企業のM&A・事業提携・投資動向
    Eurobank Ergasias SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurobank Ergasias SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ingles Markets Inc:企業の戦略・SWOT・財務分析
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …
  • EOH Holdings Ltd (EOH):企業の財務・戦略的SWOT分析
    EOH Holdings Ltd (EOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Eagle Plains Resources Ltd (EPL):企業の財務・戦略的SWOT分析
    Summary Eagle Plains Resources Ltd (Eagle Plains) operates as a mining and mineral exploration and mine development company that offers mineral resources. The company offers acquisition, exploration, mining, operations, management, production, and development gold, base metals, rare earth elements, …
  • Moog Inc (MOG.A):企業の財務・戦略的SWOT分析
    Moog Inc (MOG.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Carvajal Empaques S.A.:企業の戦略・SWOT・財務情報
    Carvajal Empaques S.A. - Strategy, SWOT and Corporate Finance Report Summary Carvajal Empaques S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Next Plc:企業の戦略・SWOT・財務情報
    Next Plc - Strategy, SWOT and Corporate Finance Report Summary Next Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • CES Energy Solutions Corp (CEU):企業の財務・戦略的SWOT分析
    CES Energy Solutions Corp (CEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆